Meloxican: Influence on arachidonic acid metabolism Part 1. In vitro findings

Biochemical Pharmacology

Volumn 51, Issue 1, 1996, Pages 21-28

  Engelhardt, G ^a   Bogel R ^a   Schnitzer, Chr ^a   Utzmann, R ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

COX 1; COX 2; Isolated enzyme; Macrophage; Meloxicam

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DEXAMETHASONE; DICLOFENAC; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; ISOXICAM; KETOPROFEN; MELOXICAM; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN E2; RADIOISOTOPE; TENIDAP;

ANIMAL CELL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; BRAIN; CATTLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME ISOLATION; GUINEA PIG; NONHUMAN; PERITONEUM MACROPHAGE; PLACENTA; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SEMINAL VESICLE; SHEEP;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARACHIDONIC ACID; BRAIN; CATTLE; CELL-FREE SYSTEM; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; GUINEA PIGS; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; PLACENTA; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SEMINAL VESICLES; SHEEP; THIAZINES; THIAZOLES;

EID: 0030030129     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02111-6     Document Type: Article

References (38)

1. Engelhardt G, Homma D, Schnitzler Chr and Utzmann R, Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new nonsteroidal anti-inflammatory agent. Inflamm Res 44: 423-433, 1995.
2. Engelhardt G, Meloxicam, a potent inhibitor of adjuvant arthritis in the rat. Scand J Rheumatol 98: (Suppl) Abstr. No. 110, 1994.
3. Lemmel EM, Bolten W, Bourgos-Vargas R, Platt PN, Nissilä M, Sahlberg D, Bjorneboe O, Baumgartner H, Valat JP, Franchimont P, Distel M, Bluhmki E and Hanft G. A double blind placebo controlled study of 7.5 and 15 mg of meloxicam in patients with rheumatoid arthritis (RA). Scand J Rheumatol 98: (Suppl) Abstr. 111, 1994.
4. Lund B, Distel M, Bluhmki E, A double blind placebo controlled study of three different doses of meloxicam in patients with osteoarthritis of the knee. Scand J Rheumatol 98: (Suppl) Abstr. 117, 1994.
5. Vane JR, Mode of action of aspirin and similar compounds. In: Prostaglandin Synthetase Inhibitors (Eds. Robinson HJ and Vane RJ), pp. 155-163. Raven Press, New York, 1974.
6. Vane JR, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol 231: 232-235, 1971.
7. Raz A, Wyche A and Needleman P, Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translational phases. Proc Natl Acad Sci USA 86: 1657-1661, 1989.
8. Xie W, Chipman JG, Robertson DL, Erikson RC and Simmons DL, Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by RNA splicing. Proc Natl Acad Sci USA 88: 2692-2696, 1991.
9. Xie W, Robertson DL and Simmons DL, Mitogen-inducible prostaglandin GIH synthase: A new target for nonsteroidal anti-inflammatory drugs. Drug Devel Res 25: 249-265, 1992.
10. Moncada S, Gryglewski R, Buntnig S and Vane JR, An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665, 1976.
11. Whittle BJR, Higgs GA, Eakins KE, Moncada S and Vane JR, Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa. Nature 284: 271-273, 1980.
12. Mitchell JA, Akarasereenont P, Thiemerman Chr, Flower R and Vane JR, Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11693-11697, 1994.
13. Vane J, Towards a better aspirin. Nature 367: 215-216, 1994.
14. Meade EA, Smith WL and DeWitt DL, Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614, 1993.
15. Lanza FL, A review of gastric ulcer and gastroduodenal injury in normal volunteers receiving aspirin and other nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 24: 24-31, 1989.
16. Garcia Rodriguez LA and Jick H, Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343: 769-772, 1994.
17. Smith WL and DeWitt D, Differential interactions of prostaglandin endoperoxide synthases with nonsteroidal anti-inflammatory drugs. Curr Opin Invest Drugs 3: 1-11, 1994.
18. Wimsatt J, Nathanielsz PW and Sirois J, Induction of prostaglandin endoperoxide synthase isoform-2 in ovine cotyledonary tissue during late gestation. Endocrinology 133: 1068-1073, 1993.
19. Flower RJ, Cheung HS and Cushman DW, Quantitative determination of prostaglandins and malondialdehyde formed by the arachinate oxygenase (prostaglandin synthetase) system of bovine seminal vesicle. Prostaglandins 4: 325-341, 1973.
20. White HL and Glassman J, A simple radiochemical assay for prostaglandin synthetase. Prostaglandins 7: 123-129, 1974.
21. Linder A, Statistische Methoden, 4th ed. pp. 148-162, Birkhäuser, Basel, 1964.
22. Fieller EC, A fundamental formula in the statistics of biological assay, and some applications. Q J Pharm Pharmacol 17: 117-123, 1944.
23. Fu JY, Masferrer JL, Seibert K, Raz A and Needleman P, The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265: 16737-16740, 1990.
24. Kujubu DA and Herschman HR, Dexamethasone inhibits mitogen induction of the TIS 10 prostaglandin synthase cyclooxygenase gene. J Biol Chem 267: 7991-7994, 1992.
25. Masferrer JL, Seibert K, Zweifel B and Needleman P, Endogenous glucocorticoids regulate inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 89: 3917-3921, 1992.
26. Masferrer JL, Zweifel BS, Seibert K and Needleman P, Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86: 1375-1379, 1990.
27. Sebaldt RJ, Shelter JR, Oates JA, Roberts LJ and Fitzgerald GA. Inhibition of eicosanoid biosynthesis by glucocorticoids in humans. Proc Natl Acad Sci USA 87: 6974-6978, 1990.
28. Vane JR, The induction of a second and different cyclooxygenase is important in inflammation. In: William Harvey Research Conference (Ed. Vane JR), Sept. 28-29, London 1992, Vol. 3, Abstr. p. 3.
29. Vane JR and Botting RM, New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 44: 1-10, 1995.
30. Flower RJ and Vane JR, Some pharmacologic and biochemical aspects of prostaglandin biosynthesis and its inhibition. In: Prostaglandin Synthetase Inhibitors (Eds. Robinson HJ and Vane JR), pp. 9-18. Raven Press, New York, 1974.
31. Engelhardt G, Zur Pharmakologie der schwach wirksamen Analgetika. In: Zur Problematik der Schwach Wirksamen Analgetika (Ed. Forth W), pp. 100-108. Braun, Karlsruhe, 1986.
32. Flower R and Vane JR, Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-Acetamidophenol). Nature 240: 410-411, 1972.
33. Yamagata K, Andreasson KL, Kaufmann WE, Barbes CA and Worley PF, Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386, 1993.
34. Chen Y, Marsh T, Zhang JS and Graham SH, Expression of cyclooxygenase 2 in rat brain following kainate treatment. Neuro Rep 6: 245-248, 1995.
35. Breder CD, DeWitt D and Kraig RP, Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 355: 196-215, 1995.
36. De Witt DL, Lanenville O, Lecomte M, Hla T, Funk C and Smith M, Selective inhibition of the human PGH-synthase-1 and -2 (cyclooxygenase) isoenzymes by aspirin and other non-steroidal anti-inflammatory drugs. In: World Congress Inflammation '93, IAIS, Vienna, October 10-15, 1993, (Abstract) pp. 154.
37. Futaki N, Takahashi S, Yokoyama M, Arai J, Higuchi S and Otomo S, An anti-inflammatory agent, NS-398, selectively inhibits PGHS-2 activity in rat endotoxin shock. In: World Congress Inflammation '93, IAIS, Vienna, October 10-15, 1993, (Abstract) p. 52.
38. Sircar JC, Prostaglandin G/H synthase isozymes: A new target for drug discovery. Curr Opin Invest Drugs 2: 403-407, 1993.